Physician profile
Christopher Cronin
NPI 1225111073
$1,068.20
in general payments reported to CMS, 2019-2025
12 companies · $246 in 2025
The $246 reported for 2025 was more than what 79% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.35 · 2020: $426 · 2021: $76.85 · 2022: $118 · 2023: $63.94 · 2024: $97.23 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scican INC | $380.95 | 2020 | |
| Straumann USA LLC | $310.25 | 2022-2025 | |
| Patterson Companies, INC. | $70.19 | 2024 | |
| Zimmer Biomet Holdings, INC. | $64.58 | 2019-2021 | |
| Dentsply Sirona INC | $64.32 | 2021-2025 | Primescan Connect, Consumable Dentistry, Suresmile |
| Zimvie INC. | $54.40 | 2022-2025 | |
| Gc America INC. | $47.22 | 2020-2021 | |
| Voco America INC. | $23.62 | 2019-2022 | |
| Biohorizons Implant Systems INC. | $14.80 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $14.52 | 2022 | |
| Planmeca USA, INC. | $12.78 | 2019 | |
| Ultradent Products INC | $10.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.